Catalogo dei prodotti della ricerca

LICHTNER, Miriam
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.173
EU - Europa 4.002
AS - Asia 2.960
SA - Sud America 264
AF - Africa 85
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.953
IT - Italia 1.686
SG - Singapore 1.598
IN - India 620
CN - Cina 537
SE - Svezia 503
UA - Ucraina 321
DE - Germania 307
FI - Finlandia 293
RU - Federazione Russa 256
BR - Brasile 178
CA - Canada 164
IE - Irlanda 128
GB - Regno Unito 98
AR - Argentina 79
BG - Bulgaria 76
AT - Austria 71
ID - Indonesia 71
NL - Olanda 57
BE - Belgio 49
FR - Francia 45
RO - Romania 41
MY - Malesia 40
BZ - Belize 30
TG - Togo 28
HK - Hong Kong 18
MX - Messico 16
CZ - Repubblica Ceca 15
PL - Polonia 13
GH - Ghana 12
EG - Egitto 9
TR - Turchia 9
CH - Svizzera 8
JP - Giappone 8
BD - Bangladesh 7
CM - Camerun 7
MO - Macao, regione amministrativa speciale della Cina 7
ZA - Sudafrica 7
AU - Australia 6
LT - Lituania 6
ES - Italia 5
IR - Iran 5
CL - Cile 4
GR - Grecia 4
IQ - Iraq 4
MK - Macedonia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BJ - Benin 3
DO - Repubblica Dominicana 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
PA - Panama 3
PH - Filippine 3
SC - Seychelles 3
TW - Taiwan 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
NO - Norvegia 2
PK - Pakistan 2
SI - Slovenia 2
TH - Thailandia 2
TN - Tunisia 2
VN - Vietnam 2
A1 - Anonimo 1
AM - Armenia 1
BF - Burkina Faso 1
BW - Botswana 1
CR - Costa Rica 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 18.493
Salva come PNG Salva come JPEG
Città #
Fairfield 1.652
Singapore 854
Chandler 816
Ashburn 781
Woodbridge 736
Dearborn 682
Rome 645
Seattle 609
Houston 556
Cambridge 538
Ann Arbor 494
Wilmington 484
Princeton 316
Plano 246
Beijing 205
San Paolo di Civitate 189
Lawrence 165
Santa Clara 159
Boston 137
San Diego 137
Millbury 136
Jacksonville 129
Milan 129
Dublin 124
Fremont 113
Ottawa 104
Andover 92
New York 92
Cosenza 81
Sofia 76
Federal 75
Helsinki 72
Jakarta 70
Boardman 67
San Jose 65
Moscow 58
Nuremberg 57
Norwalk 54
Toronto 51
Brussels 48
San Mateo 46
Falkenstein 39
Kunming 38
Dallas 37
Vienna 36
Hefei 34
Munich 32
Belize City 30
Des Moines 29
Lomé 28
London 26
Bühl 25
Falls Church 25
Yubileyny 25
Nanchang 24
Naples 23
Pune 23
Nanjing 20
Council Bluffs 19
Los Angeles 19
Mannheim 18
São Paulo 17
Buffalo 16
Jinan 16
Brno 15
Phoenix 15
Bremen 14
Guangzhou 14
Shenyang 14
Frankfurt am Main 13
Fuzhou 13
Groningen 13
Columbus 12
Grafing 12
Prato 12
Stockholm 12
Saint Louis 11
Accra 10
Chicago 10
Genoa 10
Hebei 10
Hong Kong 10
Lappeenranta 10
Padova 10
Amsterdam 9
Paris 9
Shanghai 9
Southend 9
Chongqing 8
Artena 7
Atlanta 7
Belo Horizonte 7
Brasília 7
Laurel 7
Mexico City 7
Pomezia 7
Redwood City 7
Sabaudia 7
Turin 7
Xian 7
Totale 13.100
Salva come PNG Salva come JPEG
Nome #
Study of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a population of HIV-negative migrants and HIV-infected patients attending an outpatient clinic in Rome. 172
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 149
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 148
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 146
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 145
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. 133
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) 129
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 125
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 122
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report 121
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 118
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 116
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe 113
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients 111
Infant feeding modalities and morbidity in HIV infected women in resource-poor countries. A multicenter study in sub-Saharan Africa 111
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19). Relationship with mortality 111
Multifunctional analysis of CD4+T-cell response as immune-based model for tuberculosis detection 109
Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis 108
Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy 105
Nox2 activation in covid-19 105
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 105
Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients 103
Metastatic penile squamous cell carcinoma successfully treated with cemiplimab in an HIV patient 103
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 103
Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy 100
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? 100
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis 98
Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases 97
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 96
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients. 95
Diagnostic accuracy and interobserver variability of CO-RADS in patients with suspected coronavirus disease-2019: a multireader validation study 94
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV 93
Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain 92
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 92
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen 92
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 92
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 92
Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19. a multicenter observational study 92
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 91
Pacemaker Lead Endocarditis Due to Multidrug-Resistant Corynebacterium striatum Detected with Sonication of the Device 91
Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon. 90
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study. 90
Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon 89
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA 89
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy 89
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 89
Cellule dendritiche del sangue periferico e delle urine nel cancro della vescica. 88
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 88
A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy 88
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 88
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 88
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice. Evidence of a relevant risk of death and evolution from silent to chronic infection 88
Diagnostic and therapeutic approach in a rare case of primary bilateral adrenal tuberculosis 87
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 86
Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients 86
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 86
THU-117-Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance 85
Is albumin predictor of mortality in COVID-19 85
The ADA (age-d-dimer-albumin) score to predict thrombosis in SARS-CoV-2 85
LONG TERM VAGINAL ADMINISTRATION OF LACTOBACILLUS RHAMNOSUS AS COMPLEMENTARY APPROACH TO MANAGEMENT OF BACTERIAL VAGINOSIS 84
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 84
Bartonella henselae infection presenting with ocular and hepatosplenic manifestations in an immunocompetent child 83
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 83
Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells 82
Rhodococcus equi infection of monocytes/macrophages from human immunodeficiency virus (HIV)-infected patients and healthy individuals: evaluation of intracellular killing and nitric oxide production 82
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 81
Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis 80
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression 80
Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment. 80
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 80
Postpartum fever in the presence of a fibroid: Sphingomonas paucimobilis sepsis associated with pyomyoma 80
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings. 79
Cerebrospinal fluid cytokines in patients with tuberculous meningitis 79
Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response 79
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 79
Current trends in management of hepatitis B virus reactivation in the biologic therapy era 78
QTF-Gold assay for monitoring of anti-tuberculosis therapy in subjects with active TB 78
In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir? 78
Rhodococcus equi Virulence-Associated Antigens and Specific Antibody Response in AIDS Patients Infected with R. equi 77
Marked activation of the tumour necrosis factor system in AIDS-associated cryptococcosis 77
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 77
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. 76
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection 76
HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg 76
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study. 76
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy. A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases 76
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells 76
HIV infection among illegal migrants, Italy, 2004-2007. 75
The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification 75
In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells 75
Late onset invasive pneumococcal disease in a liver transplanted patient: beyond the Austrian syndrome 75
Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia 75
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort 74
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study 74
Lack of Colonization of Methicillin-Resistant Staphylococcus aureus in a High Risk Population of Migrant and HIV-Infected Patients. 73
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. 73
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection 73
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study 73
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA 73
Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc 73
Totale 9.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020910 0 0 0 0 0 0 0 0 374 288 138 110
2020/20211.412 177 195 78 71 26 153 19 105 181 223 123 61
2021/20223.081 34 182 284 117 370 86 110 315 317 232 439 595
2022/20233.116 632 573 178 330 326 298 51 251 285 19 107 66
2023/20241.680 101 196 60 132 139 256 46 88 18 283 146 215
2024/20253.092 151 177 253 223 247 518 382 296 845 0 0 0
Totale 19.242